SYNLOGIC, INC. Income Tax Examination, Penalties and Interest Expense
SYNLOGIC, INC. (SYBX) reported Income Tax Examination, Penalties and Interest Expense of $0 for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-04.
Discontinued › Expense Statement › Interest Expense
us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense · last filed 2017-08-04
- SYNLOGIC, INC. income tax examination, penalties and interest expense for the quarter ending 2017-06-30 was $0.00.
- SYNLOGIC, INC. income tax examination, penalties and interest expense for the quarter ending 2017-03-31 was $0.00.
- SYNLOGIC, INC. income tax examination, penalties and interest expense for the quarter ending 2016-12-31 was $0.00.
- SYNLOGIC, INC. income tax examination, penalties and interest expense for the quarter ending 2016-09-30 was $0.00.
- SYNLOGIC, INC. income tax examination, penalties and interest expense for fiscal 2016 was $0.00.
- SYNLOGIC, INC. income tax examination, penalties and interest expense for fiscal 2015 was $0.00.
- SYNLOGIC, INC. income tax examination, penalties and interest expense for fiscal 2014 was $0.00.
| Period end | Income Tax Examination, Penalties and Interest Expense 3 month | Income Tax Examination, Penalties and Interest Expense 6 month | Income Tax Examination, Penalties and Interest Expense 9 month | Income Tax Examination, Penalties and Interest Expense 12 month |
|---|---|---|---|---|
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $0.00 10-Q · filed 2017-08-04 | $0.00 derived: sum of 3 quarters · filed 2017-08-04 | $0.00 derived: sum of 4 quarters · filed 2017-08-04 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-09 | $0.00 derived: sum of 2 quarters · filed 2017-05-09 | $0.00 derived: sum of 3 quarters · filed 2017-05-09 | $0.00 derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $0.00 derived: sum of 3 quarters · filed 2017-03-15 | $0.00 10-K · filed 2017-03-15 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | $0.00 10-Q · filed 2016-11-10 | $0.00 derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-15 | $0.00 10-Q · filed 2017-08-04 | $0.00 derived: sum of 3 quarters · filed 2017-05-09 | $0.00 derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-09 | $0.00 derived: sum of 2 quarters · filed 2017-05-09 | $0.00 derived: sum of 3 quarters · filed 2017-05-09 | $0.00 derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $0.00 derived: sum of 3 quarters · filed 2017-03-15 | $0.00 10-K · filed 2017-03-15 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | $0.00 10-Q · filed 2016-11-10 | $0.00 derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 | $0.00 derived: sum of 3 quarters · filed 2016-08-15 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-12 | $0.00 derived: sum of 2 quarters · filed 2016-05-12 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 10-K · filed 2016-03-30 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |